Drugs / DMF5
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00924001 | Aug 2007 → Oct 2010 | melanoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DMF5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00924001 ↗ |
| Modality | Cell therapy | “DMF5 cell therapy approach” NCT00924001 ↗ |
| Route | Intravenous | “given intravenously over 20-30 minutes” NCT00924001 ↗ |